Recently, Lukang Pharmaceutical said that it intends to acquire 60% of the equity
of Shandong Lukang Zhonghe Environmental Protection Technology Co.
, Ltd.
held by Hualu Holding Group Co.
, Ltd.
for 62.
0659 million yuan in cash.
After the completion of the acquisition, Zhonghe Environmental Protection Company will become a wholly-owned subsidiary
of the Company.
For this transaction, the independent directors of the company believe that the main purpose is to better solve the environmental protection problems that restrict the development of the enterprise, realize the effective allocation of the company's resources, and meet the company's strategic development direction and actual business needs
.
The pharmaceutical industry accelerates the "green" transformation, and pharmaceutical machinery companies need to seize the opportunity (Source: Pharmaceutical Network)
In fact, with the country's continuous attention to environmental protection issues, the pharmaceutical industry is beginning to face more and more severe environmental pressure
.
Since the beginning of this year, many pharmaceutical companies have been punished for environmental protection issues, including production restrictions, fines or suspension of production for
rectification.
Therefore, in order to cope with the current situation of the industry, which is becoming stricter environmental protection, many pharmaceutical companies have also begun to increase investment in environmental protection to deal with and rectify
.
In addition to Lukang Pharmaceutical, Northeast Pharmaceutical has also been making great efforts and vigorously grasping environmental protection work
in recent years.
It is reported that Northeast Pharmaceutical has invested more than 1 billion yuan in the construction of environmental protection projects
.
From the fourth quarter of 2020, Northeast Pharmaceutical has invested another 340 million yuan to carry out environmental protection improvement projects
covering waste gas, wastewater and comprehensive utilization.
In addition, Xinhua Pharmaceutical also invested more than 20 million yuan earlier to build its own solid waste incineration energy project
.
It is understood that the project is divided into feeding, secondary incineration, waste heat utilization, quenching neutralization, multi-level dust removal and other processes, equipment automation is high, and the treated flue gas fully meets the relevant national emission standards
.
The industry generally believes that the pharmaceutical industry, as a large energy consumer and high pollution industry, in the era of low-carbon economy and green environmental protection, is paying more and more attention to the concept of environmental protection, constantly strengthening diversified environmental protection and rectification work, and through the introduction of new environmental protection technology devices, to eliminate backward production capacity in a timely manner and improve pollution control and energy saving capabilities
.
It is worth noting that in the context of pharmaceutical companies accelerating the introduction of new environmental protection processes and new technologies, continuously improving environmental protection hardware supporting facilities, and building a clean, low-carbon and circular green manufacturing system, the industry believes that the pharmaceutical equipment industry will also usher in opportunities
for accelerated development.
It is understood that as an important part of the pharmaceutical industry chain, in order to better meet the needs of the "green" development of pharmaceutical companies, many enterprises have already begun to accelerate upgrading, innovation, more energy-saving, efficiency-enhancing, environmentally friendly pharmaceutical equipment to help the pharmaceutical industry to achieve "green" environmental protection development
.
An enterprise specializes in the research, development, design, technical consultation, technical services and other chemical equipment such as supergravity distillation equipment, supergravity bed distillation equipment, supergravity dust removal equipment, etc
.
The relevant person in charge of the enterprise said that for solvent recovery, waste gas wastewater, ammonia ammonia and other difficult substances, it can be solved
for customers one by one with high-tech technology.
There are also enterprises, focusing on the treatment of chemical wastewater and pharmaceutical wastewater, specially for high-salt wastewater, with 3D electrode equipment as the core, and developed a set of energy resource recovery, low energy consumption treatment process
.
It is understood that the process can quickly remove salt, extract acid and alkali, improve the biochemistry of wastewater, achieve the purpose of resource recovery, and have the characteristics of
high efficiency, energy saving and no solid waste generation.
epilogue
epilogue
In general, with the introduction of a series of environmental protection policies, the environmental protection storm will continue to set off
in the pharmaceutical industry.
In this context, both pharmaceutical companies and pharmaceutical machinery companies should accelerate the transformation to "green", with energy conservation and emission reduction, cleaner production, and green pharmaceuticals as the goal, and continue to develop in the direction of
high quality.
